These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30688385)

  • 41. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy: results from the ECLYPS study.
    Helsen N; Van den Wyngaert T; Carp L; De Bree R; VanderVeken OM; De Geeter F; Maes A; Cambier JP; Spaepen K; Martens M; Hakim S; Beels L; Hoekstra OS; Van den Weyngaert D; Stroobants S; ; Van Laer C; Specenier P; Maes A; Debruyne P; Hutsebaut I; Van Dinter J; Homans F; Goethals L; Lenssen O; Deben K
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1075-1082. PubMed ID: 32040611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time sensitivity: a parameter reflecting tumor metabolic kinetics by variable dual-time F-18 FDG PET imaging.
    Wong CY; Noujaim D; Fu HF; Huang WS; Cheng CY; Thie J; Dalal I; Chang CY; Nagle C
    Mol Imaging Biol; 2009; 11(4):283-90. PubMed ID: 19326175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
    Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
    Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
    Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma.
    Rasmussen GB; Vogelius IR; Rasmussen JH; Schumaker L; Ioffe O; Cullen K; Fischer BM; Therkildsen MH; Specht L; Bentzen SM
    Acta Oncol; 2015; 54(9):1408-15. PubMed ID: 26256482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defining a radiotherapy target with positron emission tomography.
    Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.
    Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
    Li P; Zhuang H; Mozley PD; Denittis A; Yeh D; Machtay M; Smith R; Alavi A
    Clin Nucl Med; 2001 Feb; 26(2):131-5. PubMed ID: 11201470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal FDG distribution patterns in the head and neck: PET/CT evaluation.
    Nakamoto Y; Tatsumi M; Hammoud D; Cohade C; Osman MM; Wahl RL
    Radiology; 2005 Mar; 234(3):879-85. PubMed ID: 15734938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
    Nicolau UR; de Jesus VHF; Lima ENP; Alves MS; de Oliveira TB; Andrade LB; Silva VS; Bes PC; de Paiva TF; Calsavara VF; Guimarães APG; Cezana L; Barbosa PNVP; Porto GCLM; Pellizzon ACA; de Carvalho GB; Kowalski LP
    PLoS One; 2018; 13(8):e0200823. PubMed ID: 30114190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
    Nam SY; Lee SW; Im KC; Kim JS; Kim SY; Choi SH; Ryu JS; Moon DH; Oh SJ; Yi BY; Kim JH; Ahn SD; Shin SS; Kim SB; Choi EK; Lee BJ
    Oral Oncol; 2005 Apr; 41(4):390-5. PubMed ID: 15792611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance.
    Helsen N; Van den Wyngaert T; Carp L; Stroobants S
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1063-1071. PubMed ID: 29478080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck.
    Jacob R; Welkoborsky HJ; Mann WJ; Jauch M; Amedee R
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(5):307-13. PubMed ID: 11528276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.
    Yue J; Yang Y; Cabrera AR; Sun X; Zhao S; Xie P; Zheng J; Ma L; Fu Z; Yu J
    Dis Esophagus; 2012 Jan; 25(1):54-61. PubMed ID: 21595781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
    Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
    Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.